Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer

In an attempt to verify the nature of amplification events at band q13 on chromosome 11 we surveyed the amplification status of ten molecular markers specific for this region (GSTP, SEA, D11S97, D11S146, BCLI, PRAD1/CCND1, HST/FGF4, INT2/FGF3, EMS1, and D11S833E) in a panel of 389 primary breast carcinoma DNA samples. Eighty‐eight tumors (23%) showed at least one of these markers amplified, but in a majority of the cases amplification encompassed more than one of the tested loci. Our data confirm that amplicons at 11q13 can cover large portions of DNA and are consistent with the existence of several cores of amplification. One important core seems to be, as previously described, centered around PRAD1/CCND1; 57 tumors (14.7%) showed amplification at PRAD1/CCND1 either alone (one tumor) or along with amplification of BCL1 or INT2/FGF3. The level of amplification of PRAD1/CCND1 sometimes exceeded that of surrounding markers. Three additional amplification events occurring independently of amplification of PRAD1/CCND1 were also detected. Centromeric to BCL1, probes to D11S97, and D11S146 detected amplification in 60 tumors (15.4%) and were often the only amplified markers. Telomeric to INT2/FGF3, D11S833E was found amplified alone in ten tumors, and it was the most amplified marker in another six cases. At a shorter distance of INT2/FGF3, EMS1 was the only amplified marker in two tumors, with a level of amplification that could exceed that of PRAD1/CCND1 and D11S833E. Our data thus suggest the existence of four independent amplified regions within band 11q13 in breast cancer. Genes Chrom Cancer 9:42‐48 (1994). © 1994 Wiley‐Liss, Inc.

[1]  David M. Livingston,et al.  Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.

[2]  R. Weinberg,et al.  Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.

[3]  D. Birnbaum,et al.  DNA amplification at 11q13.5-q14 in human breast cancer. , 1992, Oncogene.

[4]  G. Peters,et al.  Proviral insertions near cyclin D1 in mouse lymphomas: a parallel for BCL1 translocations in human B-cell neoplasms. , 1992, Oncogene.

[5]  M. J. van de Vijver,et al.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.

[6]  D. Birnbaum,et al.  DNA amplification at 11q13 in human cancer: from complexity to perplexity. , 1992, Mutation research.

[7]  C. Theillet,et al.  Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately. , 1992, Oncogene.

[8]  D. Birnbaum,et al.  Localization of 11q13 loci with respect to regional chromosomal breakpoints. , 1992, Genomics.

[9]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[10]  G. Peters,et al.  Chromosome 11q13 abnormalities in human cancer. , 1991, Cancer cells.

[11]  N. Harris,et al.  PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  O. Melnyk,et al.  Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.

[13]  C. Nguyen,et al.  D11S146 and BCL1 are physically linked but can be discriminated by their amplification status in human breast cancer. , 1991, Genomics.

[14]  J. Cairns,et al.  Amplification at chromosome 11q13 in transitional cell tumours of the bladder. , 1991, Oncogene.

[15]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[16]  E. Schuuring,et al.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. , 1991, Oncogene.

[17]  T. Shows,et al.  Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. , 1991, Oncogene.

[18]  M. Fernö,et al.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. , 1991, British Journal of Cancer.

[19]  G. Peters,et al.  Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.

[20]  C. Theillet,et al.  Proto-oncogene amplification and human breast tumor phenotype. , 1989, Oncogene.

[21]  D. Birnbaum,et al.  Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. , 1989, Oncogene.

[22]  R. Eddy,et al.  Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. , 1989, The Journal of clinical investigation.

[23]  G. Stark,et al.  Evolution and stability of chromosomal DNA coamplified with the CAD gene , 1989, Molecular and cellular biology.

[24]  P. Goodfellow,et al.  A human sequence homologous to v-sea maps to chromosome 11, band q13. , 1988, Oncogene.

[25]  G. Peters,et al.  Amplification of the int-2 gene in primary human breast tumors. , 1988, Oncogene research.

[26]  F. Alt,et al.  Human N-myc is closely related in organization and nucleotide sequence to c-myc , 1986, Nature.

[27]  G. V. Vande Woude,et al.  Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Peters,et al.  Cell transformation by Int-2--a member of the fibroblast growth factor family. , 1991, Oncogene.

[29]  D. Birnbaum,et al.  BCL-1 participates in the 11q13 amplification found in breast cancer. , 1990, Oncogene.

[30]  R. Zeillinger,et al.  HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. , 1989, Oncogene.